Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Chromosome 17p deletion in human medulloblastoma: a missing checkpoint in the Hedgehog pathway.

De Smaele E, Di Marcotullio L, Ferretti E, Screpanti I, Alesse E, Gulino A.

Cell Cycle. 2004 Oct;3(10):1263-6. Epub 2004 Oct 3. Review.

PMID:
15467454
2.

REN(KCTD11) is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma.

Di Marcotullio L, Ferretti E, De Smaele E, Argenti B, Mincione C, Zazzeroni F, Gallo R, Masuelli L, Napolitano M, Maroder M, Modesti A, Giangaspero F, Screpanti I, Alesse E, Gulino A.

Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10833-8. Epub 2004 Jul 12.

3.

Hedgehog checkpoints in medulloblastoma: the chromosome 17p deletion paradigm.

Ferretti E, De Smaele E, Di Marcotullio L, Screpanti I, Gulino A.

Trends Mol Med. 2005 Dec;11(12):537-45. Epub 2005 Nov 14. Review.

PMID:
16290230
4.

Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis.

Cogen PH, Daneshvar L, Metzger AK, Duyk G, Edwards MS, Sheffield VC.

Am J Hum Genet. 1992 Mar;50(3):584-9.

5.

Identification and characterization of KCASH2 and KCASH3, 2 novel Cullin3 adaptors suppressing histone deacetylase and Hedgehog activity in medulloblastoma.

De Smaele E, Di Marcotullio L, Moretti M, Pelloni M, Occhione MA, Infante P, Cucchi D, Greco A, Pietrosanti L, Todorovic J, Coni S, Canettieri G, Ferretti E, Bei R, Maroder M, Screpanti I, Gulino A.

Neoplasia. 2011 Apr;13(4):374-85.

6.

Suppressors of hedgehog signaling: Linking aberrant development of neural progenitors and tumorigenesis.

Di Marcotullio L, Ferretti E, De Smaele E, Screpanti I, Gulino A.

Mol Neurobiol. 2006 Dec;34(3):193-204. Review.

PMID:
17308352
7.

Tumor suppressor genes and medulloblastoma.

Cogen PH, McDonald JD.

J Neurooncol. 1996 Jul;29(1):103-12. Review.

PMID:
8817421
8.

Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.

Emadian SM, McDonald JD, Gerken SC, Fults D.

Clin Cancer Res. 1996 Sep;2(9):1559-64.

9.
10.
11.

Rapid diagnosis of medulloblastoma molecular subgroups.

Schwalbe EC, Lindsey JC, Straughton D, Hogg TL, Cole M, Megahed H, Ryan SL, Lusher ME, Taylor MD, Gilbertson RJ, Ellison DW, Bailey S, Clifford SC.

Clin Cancer Res. 2011 Apr 1;17(7):1883-94. doi: 10.1158/1078-0432.CCR-10-2210. Epub 2011 Feb 16.

12.

Cloning of a human ortholog (RPH3AL) of (RNO)Rph3al from a candidate 17p13.3 medulloblastoma tumor suppressor locus.

Smith JS, Tachibana I, Allen C, Chiappa SA, Lee HK, McIver B, Jenkins RB, Raffel C.

Genomics. 1999 Jul 1;59(1):97-101.

PMID:
10395805
13.

p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma.

Adesina AM, Nalbantoglu J, Cavenee WK.

Cancer Res. 1994 Nov 1;54(21):5649-51.

14.

Deletion mapping on chromosome 17p in medulloblastoma.

Steichen-Gersdorf E, Baumgartner M, Kreczy A, Maier H, Fink FM.

Br J Cancer. 1997;76(10):1284-7.

15.

Medulloblastoma: a problem of developmental biology.

Rubin JB, Rowitch DH.

Cancer Cell. 2002 Jul;2(1):7-8.

16.

Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation.

Park AK, Lee SJ, Phi JH, Wang KC, Kim DG, Cho BK, Haberler C, Fattet S, Dufour C, Puget S, Sainte-Rose C, Bourdeaut F, Grill J, Delattre O, Kim SK, Park WY.

Neuro Oncol. 2012 Feb;14(2):203-14. doi: 10.1093/neuonc/nor196. Epub 2011 Nov 16.

17.

Deletion mapping of the medulloblastoma locus on chromosome 17p.

Cogen PH, Daneshvar L, Metzger AK, Edwards MS.

Genomics. 1990 Oct;8(2):279-85.

PMID:
1979050
18.

Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.

Biegel JA, Janss AJ, Raffel C, Sutton L, Rorke LB, Harper JM, Phillips PC.

Clin Cancer Res. 1997 Mar;3(3):473-8.

19.

No preferential loss of one parental allele of chromosome 17p13.3 in childhood medulloblastoma.

Scheurlen WG, Krauss J, Kühl J.

Int J Cancer. 1995 Nov 3;63(3):372-4.

PMID:
7591234
20.

Infrequent p53 gene mutations in medulloblastomas.

Saylors RL 3rd, Sidransky D, Friedman HS, Bigner SH, Bigner DD, Vogelstein B, Brodeur GM.

Cancer Res. 1991 Sep 1;51(17):4721-3.

Supplemental Content

Support Center